Recently, has authors have reported the competitive inhibition of AGAT by a metformin treatment (3 × 1500 mg daily for 6 weeks) in individuals with Becker muscular dystrophy, leading to reduced concentrations of guanidinoacetic acid in both serum and urine [55]. The gene discussed is GATM; the disease is Becker muscular dystrophy.